1. Harvey, S. C. Sympathomimetic Drugs. In Remington's Pharmaceutical Sciences; Gennaro, A. R., Ed.; Mack Publ. Co.: Eaton, 1985; p. 890.
2. Ruffolo, R. R. Tetrahedron 1991, 48, 9952–9980.
3. FDA's Policy Statement for the Development of New Stereoisomeric Drugs. Food and Drug Administration, Washington, DC, 1992.
4. Investigation of Chiral Active Substances. Note for Guidance, Commission of the European Communities, Brussels, 1992.
5. Caccamese, S.; Principato, G.; Chimirri, A.; Grasso, S. Tetrahedron: Asymmetry 1996, 7, 2577–2584.